Radinsky R, Kraemer P M, Raines M A, Kung H J, Culp L A
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5143-7. doi: 10.1073/pnas.84.15.5143.
Analyses of the cellular and viral Kirsten ras genes (c-Ki-ras and v-Ki-ras, respectively) during malignant tumor progression were performed by using Kirsten murine sarcoma virus-transformed BALB/c 3T3 cells that harbor a replication-defective provirus. After injection into athymic nude mice by four different routes, primary tumors and secondary lung metastases were isolated, adapted to in vitro growth, and analyzed for DNA levels and mRNA expression of both genes for comparison with the originally injected transformed cells and untransformed 3T3 cells. For all tumors (primary or secondary), the v-Ki-ras gene was amplified and v-Ki-ras mRNA expression was highly elevated above that observed in the original transformed cell population. In two of five lung metastases from the i.v. and footpad injection routes, rearranged Ki-ras DNA sequences were observed. Micrometastases from the s.c. route of injection did not display these alterations. Injection of footpad lung tumor cells with rearrangements into a second group of animals led to multiple lung metastases with even further rearrangements correlating with more effective lung colonization/growth ability (overt lung tumors in five of eight animals less than 20 days after injection). However, reinjection of an i.v. lung tumor with rearranged Ki-ras led to no further rearrangements in the lung microfoci tumors isolated greater than 40 days after injection. These data suggest (i) the significance of amplification and elevated expression of v-Ki-ras in tumor formation, (ii) correlation of this amplification with more effective tumor progression, and (iii) the selective advantage that cells with Ki-ras DNA sequence additions have in the formation of overt lung tumors.
利用携带复制缺陷型前病毒的 Kirsten 鼠肉瘤病毒转化的 BALB/c 3T3 细胞,对恶性肿瘤进展过程中的细胞 Kirsten ras 基因和病毒 Kirsten ras 基因(分别为 c-Ki-ras 和 v-Ki-ras)进行了分析。通过四种不同途径将细胞注射到无胸腺裸鼠体内后,分离出原发性肿瘤和继发性肺转移瘤,使其适应体外生长,并分析这两个基因的 DNA 水平和 mRNA 表达,以与最初注射的转化细胞和未转化的 3T3 细胞进行比较。对于所有肿瘤(原发性或继发性),v-Ki-ras 基因均发生扩增,且 v-Ki-ras mRNA 表达水平显著高于原始转化细胞群体。在静脉注射和足垫注射途径产生的五例肺转移瘤中的两例中,观察到了 Ki-ras DNA 序列重排。皮下注射途径产生的微转移瘤未出现这些改变。将发生重排的足垫肺肿瘤细胞注射到另一组动物体内,导致多个肺转移瘤,且重排进一步增加,这与更强的肺定植/生长能力相关(注射后不到 20 天,八只动物中有五只出现明显的肺肿瘤)。然而,对静脉注射的肺肿瘤重排 Ki-ras 进行再次注射,在注射后 40 天以上分离出的肺微灶肿瘤中未导致进一步重排。这些数据表明:(i)v-Ki-ras 的扩增和高表达在肿瘤形成中的重要性;(ii)这种扩增与更有效的肿瘤进展相关;(iii)具有 Ki-ras DNA 序列添加的细胞在明显肺肿瘤形成中具有选择性优势。